Guido Eibl, MD

• Professor, Department of Surgery, UCLA
• Director, Hirshberg Laboratory for Pancreatic Cancer Research

Dr. Guido Eibl is Professor in the Department of Surgery at the David Geffen School of Medicine at UCLA and since 2014 the Director of the Hirshberg Laboratory for Pancreatic Cancer Research at UCLA.

He received his Medical Degree from the Technical University in Munich, Germany, in 1996 and started his surgical residency at the Benjamin Franklin University Hospital in Berlin, Germany. In 2000 Dr. Guido Eibl began a postdoctoral fellowship in the Hirshberg Laboratory for Pancreatic Cancer Research in the Department of Surgery at UCLA under the mentorship of Drs. Howard Reber and Joe Hines. In 2004 he was appointed to the faculty as an Assistant Professor and in 2013 became full Professor in the Department of Surgery.

His research interest has initially been in the field of acute pancreatitis and since 2000 became the study of pancreatic cancer, in particular inflammatory processes in the pathogenesis of pancreatic cancer and the role of obesity in pancreatic cancer development and progression using mostly animal models of the disease. Dr. Guido Eibl’s research has been published in more than 100 peer reviewed manuscripts and funded by the National Cancer Institute with a cumulative award of more than 15 million dollars as the Principal Investigator. He has successfully led highly productive, multi-team research programs on pancreatic cancer for the past 15 years and continues to collaborate with other teams at UCLA and Cedars Sinai to find efficacious interventions to prevent or intercept pancreatic cancer development.